For example, EGFR, which is frequently mutated to a constitutively active form in lung and breast cancer [289,290], phosphorylates and represses MOB1, inactivating LATS1/2 and resulting in hyperactive YAP/TAZ [291]. Here, YAP1 is linked to breast carcinoma.